secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0000105770-25-000039
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharmaceutical shareholders approve all proposals at 2025 annual meeting; adopt special meeting right
--------------------------------------------------------------------------------

- Shareholders elected all 12 director nominees; highest vote against was Deborah Keller (7.4M against).
- Advisory vote on executive compensation approved with 59.2M for, 3.5M against (91.4% support).
- Articles amended to allow shareholders to call special meetings, approved with 62.7M for (99.9% for).
- 2016 Omnibus Incentive Compensation Plan amended and restated, approved with 60.9M for (97.0% for).
- PricewaterhouseCoopers ratified as auditor for 2025 with 60.5M for, 4.4M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000039/0000105770-25-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000039/wst-20250506.htm
  HTML page:      https://secwatch.observer/filing/0000105770-25-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer